학술논문

Ethnicity-specific alterations of plasma and hepatic lipidomic profiles are related to high NAFLD rate and severity in Hispanic Americans, a pilot study
Document Type
article
Source
Subject
Medical Biochemistry and Metabolomics
Biomedical and Clinical Sciences
Digestive Diseases
Obesity
Clinical Research
Hepatitis
Liver Disease
Nutrition
Chronic Liver Disease and Cirrhosis
2.1 Biological and endogenous factors
Oral and gastrointestinal
Metabolic and endocrine
Ethnicity
Hispanic or Latino
Humans
Lipidomics
Liver
Non-alcoholic Fatty Liver Disease
Phospholipids
Pilot Projects
Hispanic
Nonalcoholic steatohepatitis
Lipidomic
Lipotoxicity
Medicinal and Biomolecular Chemistry
Biochemistry and Cell Biology
Biochemistry & Molecular Biology
Biochemistry and cell biology
Medical biochemistry and metabolomics
Language
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a progressive condition that includes steatosis (NAFL) and nonalcoholic steatohepatitis (NASH). In the U.S., Hispanics (HIS) are afflicted with NAFLD at a higher rate and severity compared to other ethnicities. To date, the mechanisms underlying this disparity have not been elucidated. In this pilot study, we compared untargeted plasma metabolomic profiles for primary metabolism, complex lipids, choline and related compounds between a group of HIS (n = 7) and White Caucasian (CAU, n = 8) subjects with obesity and biopsy-characterized NAFL to ethnicity-matched lean healthy controls (n = 14 HIS and 8 CAU). We also compared liver and plasma metabolomic profiles in a group of HIS and CAU subjects with obesity and NASH of comparable NAFLD Activity Scores, to BMI-matched NASH-free subjects in both ethnicities. Results highlight signs of metabolic dysregulation observed in HIS, independent of obesity, including higher plasma triglycerides, acylcarnitines, and free fatty acids. With NASH progression, there were ethnicity-related differences in the hepatic profile, including higher free fatty acids and lysophospholipids seen in HIS, suggesting lipotoxicity is involved in the progression of NASH. We also observed greater hepatic triglyceride content, higher plasma triglyceride concentrations and lower hepatic phospholipids with signs of impaired hepatic mitochondrial β-oxidation. These findings provide preliminary evidence indicating ethnicity-related variations that could potentially modulate the risk for progression of NALD to NASH.